118 related articles for article (PubMed ID: 2842550)
21. Functional properties of Ly 11.2 lymphocytes: a role for these cells in leukemia?
Meruelo D; Paolino A; Flieger N; Dworkin J; Offer M; Hirayama N; Ovary Z
J Immunol; 1980 Dec; 125(6):2719-26. PubMed ID: 6253569
[TBL] [Abstract][Full Text] [Related]
22. Suppression of natural killer cell activity by Friend murine leukemia virus.
Moody DJ; Specter S; Bendinelli M; Friedman H
J Natl Cancer Inst; 1984 Jun; 72(6):1349-56. PubMed ID: 6202923
[TBL] [Abstract][Full Text] [Related]
23. Clonal analysis of radiation leukemia virus-induced leukemic and preleukemic murine cells.
Ben-David Y; Yefenof E; Kotler M
Cancer Res; 1987 Dec; 47(24 Pt 1):6590-4. PubMed ID: 2824038
[TBL] [Abstract][Full Text] [Related]
24. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
25. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection.
Salazar-Mather TP; Ishikawa R; Biron CA
J Immunol; 1996 Oct; 157(7):3054-64. PubMed ID: 8816415
[TBL] [Abstract][Full Text] [Related]
26. Cell-associated infectivity in the blood of C57bl mice bearing a radiation-induced leukemia (RadLV/D).
Baugnet-Mahieu L; Baes C; Goutier R; Maisin JR
Biomedicine; 1978; 28(1):28-35. PubMed ID: 208673
[No Abstract] [Full Text] [Related]
27. Natural killer activity in (C57BL/6 X DBA/2)F1 hybrids undergoing acute and chronic graft-vs.-host reaction.
Pattengale PK; Ramstedt U; Gidlund M; Orn A; Axberg I; Wigzell H
Eur J Immunol; 1983 Nov; 13(11):912-9. PubMed ID: 6641788
[TBL] [Abstract][Full Text] [Related]
28. Natural killer activity, production of interferon-gamma and interleukin 2 in immunodeficient C57BL/6 mice injected with RadLV-Rs viral complex.
Vaillier D; Daculsi R; Legrand E; Guillemain B
Immunobiology; 1990 Feb; 180(2-3):195-207. PubMed ID: 2160912
[TBL] [Abstract][Full Text] [Related]
29. Radiation leukemia virus: a marker for the study of intrathymic T cell differentiation.
Boniver J; Delvenne C; Janowski M; Courtoy R; Defresne MP
Thymus; 1989; 14(1-3):109-13. PubMed ID: 2560269
[TBL] [Abstract][Full Text] [Related]
30. Effects of a cloned cell line with NK activity on bone marrow transplants, tumour development and metastasis in vivo.
Warner JF; Dennert G
Nature; 1982 Nov; 300(5887):31-4. PubMed ID: 6752725
[No Abstract] [Full Text] [Related]
31. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
Nazarov V; Hilbert D; Wolff L
Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of potential lymphoma-inducing cells in mice sensitive or resistant to lymphomagenesis by radiation leukemia virus variants.
Gokhman I; Peled A; Haran-Ghera N
Cancer Res; 1990 May; 50(9):2554-61. PubMed ID: 2158393
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms in T cell leukemogenesis. II. T cell responses of preleukemic BALB/c mice to Moloney leukemia virus antigens.
Lee JC; Horak I; Ihle JN
J Immunol; 1981 Feb; 126(2):715-22. PubMed ID: 6969759
[TBL] [Abstract][Full Text] [Related]
34. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
[TBL] [Abstract][Full Text] [Related]
35. Adoptive transfer of resistance to murine retrovirus-induced immune suppression.
Gilmore GL
Cell Immunol; 1996 Apr; 169(1):24-9. PubMed ID: 8612290
[TBL] [Abstract][Full Text] [Related]
36. Systemic and in situ natural killer activity in C57BL/6N and CBA/N mice bearing murine sarcoma virus-induced regressor tumors.
Gerson JM; Holden HT; Herberman RB
J Natl Cancer Inst; 1980 Nov; 65(5):905-7. PubMed ID: 6253708
[TBL] [Abstract][Full Text] [Related]
37. Treatment of primary radiogenic C57BL mouse cell leukemia/lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy and adjuvant cellular therapy.
Maruyama Y; Feola JM; Kryscio R
Jpn J Cancer Res; 1985 Dec; 76(12):1236-43. PubMed ID: 3005211
[TBL] [Abstract][Full Text] [Related]
38. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
Stein-Streilein J; Bennett M; Mann D; Kumar V
J Immunol; 1983 Dec; 131(6):2699-704. PubMed ID: 6644021
[TBL] [Abstract][Full Text] [Related]
39. Strain differences in natural killer cell-mediated immunity among mice: a possible mechanism for the low natural killer cell activity of A/J mice.
Whyte AL; Miller SC
Immunobiology; 1998 Jul; 199(1):23-38. PubMed ID: 9717665
[TBL] [Abstract][Full Text] [Related]
40. Depression of natural antitumor resistance of C57BL/6 mice by leukemogenic doses of radiation and restoration of resistance by transfer of bone marrow or spleen cells from normal, but not beige, syngeneic mice.
Gorelik E; Herberman RB
J Natl Cancer Inst; 1982 Jul; 69(1):89-93. PubMed ID: 7047834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
